NEW YORK, Oct. 29 (GenomeWeb News) - Sharan Pagano has been appointed vice president
of business development at Genstruct, the Cambridge, Mass., biotechnology company said today.
Pagano joins Genstruct from Incyte, where she was in sales and marketing, including senior director of business development and marketing. She has also worked at Genetics Institute, as manager in emerging businesses.
Philip Leder, head of the department of genetics at Harvard Medical School, has been elected to the board of directors at Schering-Plough, the company said today.
Leder's position will begin Nov. 1. He is also a senior investigator of the Howard Hughes Medical Institute, and an honorary trustee of the Massachusetts General Hospital, chairman of the Board of the Charles A. Revson Foundation, a trustee of the Foundation for Advanced Education in the Sciences, and the Hadassah Medical Organization. He held research positions at the National Institutes of Health between the early 1960s and 1980, when he joined the faculty at Harvard.
Joseph Rodriguez has been appointed senior vice president of Human Resources at Invitrogen, the company said Oct. 28. Rodriguez comes to Invitrogen from Home Depot, where he worked in global human resources management. He has also served in similar roles at Allied Signal and PepsiCo.
Charles Lillis has been appointed to the board of directors of SomaLogic, the Boulder, Colo., proteomics company said Oct. 28.
Lillis is currently on the board of several companies, including SuperValu and Williams Companies, and is co-founder and managing partner of LoneTree Capital, a venture capital group that invests mainly in the information and communications industry.
Previously, Lillis served as chairman and CEO of Media One Group, which owned and operated cable systems, wireless, and interactive multimedia service businesses.
Paul Billings has been named vice president national director of genetics and genomics at Laboratory Corporation of America Holdings, the Burlington, NC company said Oct. 27.
Billings, who will head efforts to provide genomic and genetic tests and services at the company, comes to LabCorp from WIPRO, where he was a vice president for life sciences and clinical affairs at WIPRO HealthSciences, its subsidiary. He is also the author of the book, DNA on Trial: Genetic Identification and Criminal Justice, and has acted as executive vice president and chief scientific and medical officer at Genesage. He has also held clinical faculty appointments at Harvard Medical School, the University of California at San Francisco, and Stanford; and has served as chief of the division of Genetic Medicine and vice-chairman of the Department of Medicine at California Pacific Medical Center in San Francisco.
John Wilkins, who is director of the Manitoba Center for Proteomics and a professor of immunology at the University of Manitoba, has been appointed to the scientific advisory board of Miraculins a disease protein identification company in Winnipeg.
Wilkins joins Kenneth Standing and Werner Ens on the advisory board. He is also director of the Canadian Genetic Diseases "Immunoprobe Centre"; and project leader of the Canadian Institutes of Health Research BiomedicalProteomics Program.
Hans Johansson, the current president of Pyrosequencing, will become the head of the biosystems business area at the company, Pyrosequencing said Oct. 23. David Patteson, president of Biotage, which Pyrosequencing has acquired, will be head of discovery chemistry.
Jeff Bork, the chairman of the board and CEO of Pyrosequencing, will become president and CEO. Ove Mattson, chairman of the board of Personal Chemistry, (which the company merged with in September) will become chairman of the board of the new company.